Close Menu

NEW YORK(GenomeWeb) — Danaher today initiated guidance for adjusted diluted EPS for 2015 in the range of $4.35 to $4.45. 

The guidance assumes core revenue growth of 3 percent to 4 percent and excludes anticipated non-cash amortization for 2015 of $440 million, or $.46 per share, compared to about $380 million, or $40 per share, in 2014.  

The company also reaffirmed GAAP diluted EPS for the fourth quarter of 2014 to be in the range of $1 to $1.04. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.